A recent study found that rapid-acting antidepressants like ketamine and psychedelics may relieve depression by regulating ...

T hree years ago, Blake Mycoskie came out of semi-retirement years after selling his shoe brand Toms to announce a new ...

The more disordered a person’s brain activity became during their first psilocybin trip, the more their well-being tended to ...

Researchers gathered 62 people who had never taken a psychedelic before, gave them 19 milligrams of psilocybin, a common ...

Psychedelics show promise for depression and anxiety. Federal support is growing, but drugs are advancing at different speeds ...

A landmark PET-MRI study has for the first time quantified how LSD occupies serotonin 2A receptors in the living human brain ...

A new report from a bipartisan psychedelics caucus in Congress summarizes stakeholders’ views on how the therapeutic use of ...

The possibility of psychedelic therapies for PTSD or treatment-resistant depression in the U.S. has never been greater. But even as the industry inches closer to an FDA go-ahead, the realities of ...

Influential figures in Elon Musk's circle are investing in psychedelic therapeutics, aiming to integrate drugs like MDMA and psilocybin into mainstream mental health treatments, despite regulatory ...

Ezell is a social epidemiologist and assistant professor at the University of Chicago Medical Center. Choi is a health services researcher and assistant professor at New York University Grossman ...

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could tackle the problem with blinding and produce more reliable results.

Plus, how his relationship with his mom's memory has evolved ...